Artificial intelligence (AI) technology developer AI Metrics has signed advanced visualization software firm Imaging Biometrics as a global distribution partner for its virtual liver biopsy software. Source: AI Metrics joins forces with Imaging Biometrics

PET imaging with copper-64 (Cu-64) DOTATATE could become a lower-radiation dose option for patients with suspected neuroendocrine tumors, according to the results of a phase III clinical trial published online January 10 in the Journal of Nuclear Medicine. Source: Cu-64 DOTATATE PET could handle neuroendocrine tumors

Source: ‘The AI is simply outstanding’: Algorithm spots prostate cancer similarly to expert pathologists

Source: Limiting clinical disagreements key to reducing variability in CT measurements

Source: PET tracer can help fight heart attacks earlier in the process

Source: System combining laser imaging, AI may make cancer operations safer and more effective

Source: Tau PET imaging beats amyloid-based approach in battle against Alzheimer’s

Source: Google’s AI system rivals radiologists at detecting breast cancer

Change Healthcare’s enterprise imaging platform is an integrated modular solution spanning radiology, cardiology and care settings with imaging needs. This reliable and scalable solution spans vertically through large IDNs and horizontally across independent hospital sections aggregating data to a single point of access, simplifying health IT infrastructure. Source: Change Healthcare Enterprise Imaging™

Source: Optical imaging may be ‘game-changer’ for predicting heart attacks